Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

OPC-1085

Known as: OPC 1085, OPC1085 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
Cardiac electrophysiologic action of a new beta‐adrenergic blocking agent carteolol hydro‐chloride, or OPC‐1085, was studied in… Expand
1977
1977
The pharmacokinetics of 5-(3-tert.-butylamino-2-hydroxy)-propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol hydrochloride… Expand
1977
1977
The kinetics (absorption, distribution and excretion) of carteolol were investigated after oral and intravenous administration to… Expand
1977
1977
1. The antiarrhythmic properties of 5–(3‐tert‐butylarnino‐2‐hydroxy)propoxy‐3,4‐dihydrocarbostyril hydrochloride (OPC‐1085) were… Expand
1977
1977
Effects of a newly synthesized beta-blocker, 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril (OPC-1085) were… Expand
1977
1977
The effects of carteolol, propranolol and alprenolol were studied by using spontaneously contracting atria, atrial muscle and… Expand
1976
1976
Distribution of a new beta-adrenergic blocking agent, 3H-carteolol in mice was studied by whole body autoradiography. The… Expand
Highly Cited
1974
Highly Cited
1974
The beta-adrenergic blocking and hemodynamic properties of 5-(3-tert-butyl-amino-2-hydroxy) propoxy-3,4-dihydrocarbostyril… Expand